Paid Clinical Trials in Scarborough, ME
As of July 2026, 95 paid clinical trials are recruiting in Scarborough, Maine. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Scarborough offers studies at sites including MaineHealth Maine Medical Center- Scarborough for conditions such as Acute Myeloid Leukemia, Breast Cancer, Malignant Solid Neoplasm, Ovarian Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Scarborough
Trials by drug in Scarborough
Filter results
92 clinical trials
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Nectero EAST System Clinical Study
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Clinical Outcome Measure at Stryker Spine
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Top Research Study Locations in Scarborough
Researchers run research studies in Scarborough, ME at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MaineHealth Maine Medical Center- Scarborough | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Lung Non-Small Cell Carcinoma | 41 |
| Maine Children's Cancer Program | B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular | 25 |
| New England Cancer Specialists | Breast Cancer, HER2-positive Breast Cancer, Chronic Lymphocytic Leukemia | 6 |
| Maine Medical Center - Scarborough Campus | Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms | 3 |
| Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer | 2 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Local Institution - 0127 | Metastatic Non-small Cell Lung Cancer With MTAP Deletion | 1 |
| MMP Neurology | Focal Epilepsy, Tonic-Clonic Seizures | 1 |
| Maine Center For Cancer Medicine | Ovarian Cancer | 1 |
| Maine Health Cancer Care | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | 1 |
| Maine Health Cardiology | Cardiovascular Disease and Lipoprotein(a) | 1 |
| Maine Hemophilia and Thrombosis Center | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 1 |
| Maine Medical Center | Locally Advanced Solid Tumors, Lymphoma, Metastatic Solid Tumors | 1 |
| Maine Medical Center- Scarborough Campus | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Maine Medical Partner's Women's Health | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| Maine Medical Partners MaineHealth Cardiology | Atrial Fibrillation | 1 |
| Maine Medical Partners-Woman's Health-Division of Gynecologic Oncology | Cervical Cancer | 1 |
| MaineHealth | Type B Aortic Dissection | 1 |
| MaineHealth Cancer Care - Scarborough | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| MaineHealth Cancer Care and Blood Disorders Scarborough | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| MaineHealth Cardiology | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| MaineHealth Neurosurgery and Spine | Degenerative Disc Disease, Degenerative Scoliosis | 1 |
| MaineHealth Pediatric Neurology | Headache, Migraine | 1 |
| MaineMed Vascular Surgery | Abdominal Aortic Aneurysm | 1 |
| Massive Bio SYNERGY-AI site | BRCA Gene Rearrangement, Bladder Cancer, Breast Cancer | 1 |
Active & Upcoming Studies in Scarborough (2026)
Recruiting trials in Scarborough grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (67 active studies)
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) · Phase 3 · Merck Sharp & Dohme LLC
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Neurology & pain (2 active studies)
- Adolescent Lifestyle Medicine Headache Study · MaineHealth
- An Open-label Study of XEN1101 in Epilepsy · Phase 3 · Xenon Pharmaceuticals Inc.
Vaccines (1 active study)
Diabetes & metabolic (1 active study)
- A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · Phase 2 · Children's Oncology Group
Cardiovascular (1 active study)
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation · Phase 3 · Johns Hopkins University
Common conditions studied in Scarborough
- Acute Myeloid Leukemia (8 active studies)
- Breast Cancer (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Ovarian Cancer (5 active studies)
- Acute Myeloid Leukemia Post Cytotoxic Therapy (3 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
Leading research sponsors in Scarborough
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Scarborough?
There are approximately 95 recruiting clinical trials in Scarborough, Maine listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scarborough pay participants?
Most recruiting trials in Scarborough compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scarborough?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scarborough?
The most common conditions under active study in Scarborough include Acute Myeloid Leukemia (8), Breast Cancer (5), Malignant Solid Neoplasm (5), Ovarian Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scarborough?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scarborough on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scarborough?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scarborough?
Recruiting research sites in Scarborough include MaineHealth Maine Medical Center- Scarborough, Maine Children's Cancer Program, New England Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scarborough right now?
The largest active categories in Scarborough are Cancer & tumors (67), Neurology & pain (2), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.